Drug class in one race
MAPT mRNA (RNAi/ASO) drugs for Alzheimer's Disease
5 tracked MAPT mRNA (RNAi/ASO) drugs in the Alzheimer's Disease race. The class explanation lives on the MAPT mRNA (RNAi/ASO) page; the full indication pipeline across every mechanism is on the Alzheimer's Disease page.
1 Phase 21 Phase 1/23 Phase 1
Head-to-head evidence: ALN-5288 vs Diranersen · ARO-MAPT-SC vs Diranersen · Diranersen vs DNL628 · Diranersen vs LY3954068